Related news from
Mon, 01 Apr 2024 10:32:05 +0000	IRADIMED CORPORATION's (NASDAQ:IRMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? IRADIMED (NASDAQ:IRMD) has had a rough three months with its share price down 7.0%. But if you pay close attention, you...
Wed, 13 Mar 2024 20:30:00 +0000	IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimed’s Investor page at https://www.iradimed.com/investors/events. This ye
Wed, 13 Mar 2024 18:03:41 +0000	Those who invested in IRADIMED (NASDAQ:IRMD) three years ago are up 93% One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger...
Mon, 26 Feb 2024 10:21:14 +0000	Calculating The Intrinsic Value Of IRadimed Corporation (NASDAQ:IRMD) Key Insights The projected fair value for IRadimed is US$35.82 based on Dividend Discount Model IRadimed's US$42.39...
Mon, 19 Feb 2024 15:18:16 +0000	Should You Invest in IRadimed Corporation (IRMD)? Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Despite growing by 12.70% net of fees in the fourth quarter, the strategy was unable to match the 15.64% return of the Russell Micro Cap Growth Index. Underperformance was mostly caused […]
Sun, 11 Feb 2024 13:45:29 +0000	Institutional investors own a significant stake of 39% in IRadimed Corporation (NASDAQ:IRMD) Key Insights Institutions' substantial holdings in IRadimed implies that they have significant influence over the...
Fri, 09 Feb 2024 14:55:31 +0000	IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call Transcript IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call Transcript February 8, 2024 IRadimed Corporation beats earnings expectations. Reported EPS is $0.39, expectations were $0.37. IRMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the IRadimed Corporation Fourth Quarter of […]
Thu, 08 Feb 2024 13:38:10 +0000	iRadimed Corp (IRMD) Reports Record Revenues and Robust Earnings Growth in Q4 and Full-Year 2023 Company Initiates Quarterly Dividend Following a Strong Fiscal Performance
Thu, 08 Feb 2024 13:05:00 +0000	IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter of 2023. Reports GAAP diluted EPS of $1.35 and non-GAAP diluted EPS of $1.48 for the full year of 2023. Reports fourth quarter of 2023 operating income of $5.2 million, an increase of 21.3%, compared to the same period in 2022 and full-year operating income of $20.0 million, an increase of 28.2%, com
Thu, 01 Feb 2024 21:05:00 +0000	IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th. WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.
Tue, 09 Jan 2024 13:30:00 +0000	IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible medical devices, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023. The fourth-quarter revenue totaled approximately $17.5 million, bringing revenue for 2023 to approximately $65.6 million, up 23% fro
Sun, 07 Jan 2024 13:30:32 +0000	What Is IRadimed Corporation's (NASDAQ:IRMD) Share Price Doing? IRadimed Corporation ( NASDAQ:IRMD ), might not be a large cap stock, but it saw a double-digit share price rise of...
Tue, 02 Jan 2024 21:30:00 +0000	IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices, today announced that the Company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference. Iradimed’s CEO, Roger Susi, is scheduled to present on Thursday, January 11, 2024, at 12:00 p.m. Pacific Time. Interested parties may access a live and archived webcast of the
Sat, 16 Dec 2023 06:01:22 +0000	Insider Sell Alert: Director James Hawkins Sells Shares of iRadimed Corp (IRMD) In a notable insider transaction, Director James Hawkins has parted with 10,468 shares of iRadimed Corp (NASDAQ:IRMD) on December 14, 2023.
Tue, 12 Dec 2023 15:00:00 +0000	IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding common stock. The regular quarterly dividend is $0.15 per share. The special cash dividend and the quarterly dividend are payable on January 12, 2024, to shareholders of record at the close of business on December 22
Wed, 06 Dec 2023 15:35:54 +0000	Why We Like The Returns At IRadimed (NASDAQ:IRMD) Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Thu, 30 Nov 2023 14:00:00 +0000	IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes Forbes 2024 America's Most Successful Small Companies WINTER SPRING, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named on Forbes’ latest list of America’s Most Successful Small-Cap Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring syst
Fri, 17 Nov 2023 13:10:00 +0000	5 Small Hidden Gems for the Rest of 2023 We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These are: HCI, LMB, IRMD, GHM, MNTX.
Tue, 14 Nov 2023 08:03:08 +0000	Insider Sell: Director Anthony Vuoto Sells 3,055 Shares of iRadimed Corp (IRMD) Director Anthony Vuoto of iRadimed Corp (NASDAQ:IRMD) has recently sold 3,055 shares of the company's stock, according to a new filing with the Securities and Exchange Commission.
Sun, 05 Nov 2023 14:23:30 +0000	IRadimed Corporation (NASDAQ:IRMD) Q3 2023 Earnings Call Transcript IRadimed Corporation (NASDAQ:IRMD) Q3 2023 Earnings Call Transcript November 3, 2023 IRadimed Corporation beats earnings expectations. Reported EPS is $0.43, expectations were $0.37. Operator: Welcome to the IRadimed Corporation Third Quarter of 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, November 3, 2023, and contains time-sensitive information […]